Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANTERN: LYR-210 in Chronic Sinusitis
NCT04041609Phase 2Completed
- Sponsor
- Lyra Therapeutics, Inc.
- Start
- May 2019
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of mometasone in chronic rhinosinusitis (CRS), sponsored by Lyra Therapeutics, Inc.. Started May 2019; status: completed.
02
Drugs
mometasone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT04041609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04041609.